Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) | MicrobiomeTrials← Back to trialsNCT06906627
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-10-28Est. Completion: 2027-04-01
Enrollment target: 750 participants Locations- University of Alabama, Birmingham, Alabama, United States
- Orlando Health, St. Petersburg, Florida, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Essentia Health, Duluth, Minnesota, United States
- Duke University, Durham, North Carolina, United States
- Houston Methodist, Houston, North Carolina, United States
- Baylor Scott & White, Temple, Texas, United States
Other microbiome trials you might be interested in
Chronic Kidney Disease-Associated Pruritus in Hemodialysis
This is a randomized, open-label, multi-center clinical study aimed at evaluating the efficacy and safety of 12 weeks of…
Beijing, ChinaEst. completion Dec 31, 2028
Obesity
Obesity promotes chronic kidney disease and is accelerating its shift to the stage of renal replacement. Bariatric surge…
Nice, FranceCompleted Mar 20, 2018